UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19

American journal of respiratory and critical care medicine, 2023-02, Vol.207 (3), p.261-270

2023

Volltextzugriff (PDF)

Pilot-scale production of expansile nanoparticles: Practical methods for clinical scale-up

Journal of controlled release, 2021-09, Vol.337, p.144-154

2021

Volltextzugriff (PDF)

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

Clinical cancer research, 2010-08, Vol.16 (15), p.3887-3900

2010

Volltextzugriff (PDF)

Small bowel and abdominal wall transplantation: A novel technique for synchronous revascularization

American journal of transplantation, 2019-07, Vol.19 (7), p.2122-2126

2019

Volltextzugriff (PDF)

Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models

Clinical cancer research, 2006-03, Vol.12 (5), p.1606-1614

2006

Volltextzugriff (PDF)

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

Alzheimer's research & therapy, 2011-09, Vol.3 (5), p.28-28

2011

Volltextzugriff (PDF)

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

Journal of Cancer, 2019-01, Vol.10 (15), p.3344-3351

2019

Volltextzugriff (PDF)

The in vitro and in vivo effects of JNJ-7706621 : A dual inhibitor of cyclin-dependent kinases and aurora kinases

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (19), p.9038-9046

2005

Volltextzugriff (PDF)

Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models

Cancer chemotherapy and pharmacology, 2011-06, Vol.67 (6), p.1415-1422

2011

Volltextzugriff (PDF)

Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

Molecular pharmacology, 2008-02, Vol.73 (2), p.338-348

2008

Volltextzugriff (PDF)

Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents

Journal of medicinal chemistry, 2004-10, Vol.47 (22), p.5367-5380

2004

Volltextzugriff (PDF)

A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models

Molecular pharmacology, 2004-09, Vol.66 (3), p.635-647

2004

Volltextzugriff (PDF)

Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation

ACS nano, 2023-02, Vol.17 (3), p.2212-2221

2023

Volltextzugriff (PDF)

GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts

International journal of oncology, 2002-07, Vol.21 (1), p.65

2002

Volltextzugriff (PDF)

Abstract LB-95: Estrogen receptor mRNA-directed therapy for triple-negative breast cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.LB-95-LB-95

2014

Volltextzugriff (PDF)

Abstract B298: The controlled local expression of IL-12 as an immunotherapeutic treatment of glioma through the use of the Rheoswitch Therapeutic System® (RTS®) platform

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B298-B298

2013

Volltextzugriff (PDF)

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides

International journal of oncology, 2001-05, Vol.18 (5), p.1061

2001

Volltextzugriff (PDF)

Abstract LB-210: Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-210-LB-210

2013

Volltextzugriff (PDF)

Abstract 5095: Differential sensitivity to dietary restriction in xenograft models harboring PI3K pathway mutations in nude mice

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5095-5095

2010

Volltextzugriff (PDF)

Abstract 1554: Corticorelin acetate, a synthetic corticotropin releasing factor, demonstrates antiangiogenic and antitumor activity alone and enhances bevacizumab activity in human tumor models

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1554-1554

2010

Volltextzugriff (PDF)

Preclinical activity of an i.v. formulation of rubitecan in IDD-P™ against human solid tumor xenografts

Anti-cancer drugs, 2002-10, Vol.13 (9), p.965-975

2002

Volltextzugriff (PDF)

The Fecal Microbiome in Pediatric Patients With Short Bowel Syndrome

JPEN. Journal of parenteral and enteral nutrition, 2016-11, Vol.40 (8), p.1106-1113

2016

Volltextzugriff (PDF)

Race, Income, and Disease Outcomes in Juvenile Dermatomyositis

The Journal of pediatrics, 2017-05, Vol.184, p.38-44.e1

2017

Volltextzugriff (PDF)

Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB107:01 and Severe Myositis in Juvenile Myositis Patients

Arthritis care & research (2010), 2017-07, Vol.69 (7), p.1088-1094

2017

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Science & Technology
(25)
Life Sciences & Biomedicine
(23)
Female
(16)
Animals
(11)
Male
(11)
Mice
(11)
Child
(9)
Mice, Nude
(8)
Adolescent
(7)
Biological And Medical Sciences
(7)
Child, Preschool
(7)
Medical Sciences
(7)
Oncology
(7)
Rheumatology
(7)
Antineoplastic Agents
(6)
Pharmacology & Pharmacy
(6)
Pharmacology. Drug Treatments
(6)
Antineoplastic Agents - Therapeutic Use
(4)
Infant
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19

Pilot-scale production of expansile nanoparticles: Practical methods for clinical scale-up

Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy

Small bowel and abdominal wall transplantation: A novel technique for synchronous revascularization

Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium

The in vitro and in vivo effects of JNJ-7706621 : A dual inhibitor of cyclin-dependent kinases and aurora kinases

Corticorelin acetate, a synthetic corticotropin-releasing factor with preclinical antitumor activity, alone and with bevacizumab, against human solid tumor models

Cellular and in Vivo Activity of JNJ-28871063, A Nonquinazoline Pan-ErbB Kinase Inhibitor That Crosses the Blood-Brain Barrier and Displays Efficacy against Intracranial Tumors

Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent Structure−Activity Relationships for a Novel Class of Antitumor Agents

A Vascular Endothelial Growth Factor Receptor-2 Kinase Inhibitor Potentiates the Activity of the Conventional Chemotherapeutic Agents Paclitaxel and Doxorubicin in Tumor Xenograft Models

Radiolabeled Biodistribution of Expansile Nanoparticles: Intraperitoneal Administration Results in Tumor Specific Accumulation

A Multidimensional Bioinformatic Platform for the Study of Human Response to Surgery

GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts

Abstract LB-95: Estrogen receptor mRNA-directed therapy for triple-negative breast cancer

Abstract B298: The controlled local expression of IL-12 as an immunotherapeutic treatment of glioma through the use of the Rheoswitch Therapeutic System® (RTS®) platform

Potentiation of antitumor activity of irinotecan by chemically modified oligonucleotides

Abstract LB-210: Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma

Abstract 5095: Differential sensitivity to dietary restriction in xenograft models harboring PI3K pathway mutations in nude mice

Abstract 1554: Corticorelin acetate, a synthetic corticotropin releasing factor, demonstrates antiangiogenic and antitumor activity alone and enhances bevacizumab activity in human tumor models

Preclinical activity of an i.v. formulation of rubitecan in IDD-P™ against human solid tumor xenografts

The Fecal Microbiome in Pediatric Patients With Short Bowel Syndrome

Race, Income, and Disease Outcomes in Juvenile Dermatomyositis

Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB107:01 and Severe Myositis in Juvenile Myositis Patients

Suchergebnisse filtern